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Protein sequences containing redundant segments of
secondary structure at both termini have the choice a priori
of folding into several possible circularly permuted variants
of the wild-type tertiary structure. To test this hypothesis the
gene of phosphoribosyl anthranilate isomerase from yeast,
which is a single-domain 8-fold /3a barrel protein, was
modified to produce a 10-fold /3a homologue in Escherichia
coli. It contained a duplicate of the two C-terminal /3a units
of supersecondary structure fused to its N-terminus. Most of
the protein was recovered from the insoluble fraction of
disrupted cells by dissolution in guanidinium chloride
solutions and refolding. Pristine protein was purified from
the soluble fraction. The purified (/3a)i0 proteins were
enzymkally almost fully active. Absorbance, fluorescence and
circular dichroism spectra as well as the reversible unfolding
behaviour of both proteins were also very similar to the
properties of the original (/3a)8 protein. Digestion with
endopeptidases converted both the pristine and the refolded
(/3a)io variant to the same large fragment that had the
N-terminal sequence and mol. wt of the wild-type 03a)g
protein. The data suggest that the folding of the (jSa)|0
variant is controlled thermodynamically both in vivo and in
vitro.
Key words: /3a barrel/circular permutation/protein folding/
terminal repeat/TIM barrel
Introduction
It is still unknown how the amino acid sequence of a protein deter-
mines its three-dimensional structure (Anfinsen and Scheraga,
1975; Jaenicke, 1987). A novel experimental approach towards
solving the protein folding problem is to study proteins whose
sequence has been altered at the genetic level (Goldenberg, 1988;
Alber, 1989). The substitution of one or more amino acids can
in principle identify single residues that are crucial either for the
pathway towards the folded structure (Yu and King, 1988) or
for its stability (Pakula and Sauer, 1989; Lim and Sauer, 1989).
However, more radical changes, such as insertions and deletions
(Castagnoli et al., 1989) or the exchange of surface loops
(Wharton et al., 1984; Riechmann ex al, 1988; Hynes et al.,
1989), are also tolerated in certain cases.
Another way of altering the protein sequence drastically is to
permute it circularly. This approach was pioneered by
Goldenberg and Creighton (1983), who used chemical condensa-
tion and limited proteolysis to permute bovine trypsin inhibitor.
We have recently shown that two circularly permuted versions
of the TRP-1 gene of yeast can be expressed in Escherichia coli
to produce two different, catalytically active variants of
phosphoribosyl anthranilate isomerase (PRAI; Luger et al.,
1989). The ability of proteins with circularly permuted sequences
to fold spontaneously to active molecules proves that both the
original termini and the particular surface loops that were cleaved
to create the new termini are unimportant for protein folding.
The structure of PRAI from E. coli is known (Priestle et al.,
1987), and modelling studies with the homologous yeast PRAI
(M.Wilmanns, unpublished work) show that it probably has the
same fold, namely that of an 8-fold /3a barrel. This symmetrical
fold was first found in triosephosphate isomerase and has since
been observed in at least 16 different enzymes (Chothia, 1988).
Circular permutation of PRAI at the three-dimensional level
is illustrated schematically (Steinberg and Thornton, 1977) in
Figure 1. The adjacent wild-type N- and C-termini (N and C
in Figure 1 A) are connected by an oligopeptide linker, and a sur-
face loop is cleaved to create new termini. In the case of one
of the circularly permuted variants of PRAI the new termini are
between a helix 6 and /3 strand 7 (cPRAI-1, N' and C in Figure
IB). In the case of the other unorthodox variant, which begins
with an a helix rather than a /3 strand, the new termini are
between /3 strand 6 and a helix 6 (cPRAI-2, Figure 1C).
It occurred to us that addition of a duplicated segment of
supersecondary structure (or 'folding unit'; Levitt and Chothia,
1976) from one terminus to the opposite terminus of PRAI would
create a novel sequence with redundant folding information.
Figure 2 illustrates this point with a two-dimensional representa-
tion of a terminally repeated (/3a))0 variant of PRAI. The eight
sequential /3a units of the wild-type PRAI (see Figure 1A) have
been 'rolled out' with the side chains of the internal hydrophobic
core below the plane of the paper. The mutual orientation of /3
strands and a helices is preserved. For illustration the Pa units
7 and 8 from the C-terminus of PRAI are duplicated and
connected to its N-terminus, with apostrophes indicating the
sequence identity.
Lasters et al. (1988) have argued that 10-fold |Sa barrels are
probably less stable than 8-fold /3a barrels. Detailed studies of
the packing of side chains in the core of (/3a)8 proteins by Lesk
et al. (1989) support this view. Therefore it is likely that the
(/3a)io variant can only fold to a (/3a)g barrel. As shown by the
brackets in Figure 2, this sequence of /3 strands and a helices
has, in principle at least, five different 'folding frames'. The core
domain of each of these alternatives contains a circular permuta-
tion of the wild-type amino acid sequence. Frame E corresponds
to the wild type (see Figure 1A) and frame A to the known
circularly permuted variant cPRAI-1 (see Figure IB). Therefore
these two folding frames have a high probability of folding to
a stable (/fo)8 core. No circular permutations corresponding to
folding frames B, C and D are known. Whereas the (/3a)g core
of C represents a conventional barrel in that it begins with a /3
strand, the (/3a)g cores of B and D are unorthodox. However,
by beginning with an a helix they resemble the unorthodox fold
of cPRAI-2 (see Figure 1C). Therefore folding frames B, C and
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wild-type PRAI circulary permuted PRAI
(cPRAI-1)
circulary permuted PRAI
(cPRAI-2)
Fig. 1. The (/?a)g barrel structure of phosphoribosyl anthranilate isomerase (PRAI) and two circularly permuted variants (Luger et al., 1989). Schematic view
down the central axis of the barrel (Stemberg and Thornton, 1977) with the C-ends of the perpendicular /3 strands (A) pointing up. These are numbered
sequentially from the wild-type N-terminus (N), and are connected by external perpendicular a helices (O). The a helices are numbered as the preceding /3
strands, and have their C-ends pointing down. (C) C-terminus of the wild-type sequence at the end of a helix 8. Solid lines represent the loops connecting
strands to helices at the top of the barrel and dashed lines represent loops connecting helices to strands at the bottom of the barrel. The active site of PRAI is
above the plane of the paper. (A) Wild-type PRAI. (B) First circularly permuted variant (cPRAI-1). The original termini were connected by a new
oligopeptide linker ( • • • ) . The new N- (N') and C-termini (C) were generated by cleaving the loop between a helix 6 and /3 strand 7. (C) Second circularly
permuted variant cPRAI-2, with new termini between /3 strand 6 and a helix 6. For partial sequences of critical loops see Figure 4.
D of the 03a) io variant also have a good chance a priori of
folding to stable (J3a)s cores.
The work described here had the following objectives, (i) Does
the presence of redundant segments of supersecondary structure
in the protein sequence affect the overall rate and extent of protein
folding? (ii) If folding occurs, which is the preferred folding
frame? (iii) Would the products of folding in vivo and in vitro
have the same folding frame? It is conceivable that the folding
frame A is preferred in vivo, if folding proceeds from the
N-terminus.
The gene corresponding to the (J3a)i0 variant of PRAI shown
schematically in Figure 2 was constructed, and expressed in
E.coli. The gene product was purified to homogeneity from both
the soluble and the insoluble cell fractions. Both the pristine
protein and the preparation obtained after refolding from solutions
of guanidinium chloride (GuCl) were almost fully active.
Preliminary investigations suggest that both have the wild-type
03a)8 folding frame, with the redundant sequence protruding
from the N-terminus. These results were presented at the AAAS
meeting in San Francisco in January 1989 and have been
commented on previously by Goldenberg (1989).
Materials and methods
Materials
Restriction enzymes and other DNA-modification enzymes were
purchased from Pharmacia, Staehelin or Boehringer. The DNA-
sequencing kit was from United States Biochemical Corp.;
acrylamide and urea for sequencing gels were from Biorad.
Oligonucleotides for sequencing and for mutagenesis were
synthesized on an Applied Biosystems ABI380B oligonucleotide
synthesizer and purified using the Beckman HPLC system with
a Waters /*Bondpak C-18 column (McLaughlin and Krusche,
1982). GuCl grade I, which was used for protein purification,
was purchased from Sigma, and ultrapure GuCl, which was used
for spectroscopic studies, was from Schwarz-Mann. Chromato-
media were brought from Pharmacia. Hydroxylapatite,
synthesized according to Atkinson et al. (1973), was a kind gift
from Ciba-Geigy, Basel. Proteases were purchased from
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Fig. 2. Schematic two-dimensional representation of the (/3a)|0 variant of
PRAI and its folding frames. The /Sor supersecondary structure units (see
Figure 1A) are rolled out in the plane. They are boxed and numbered
sequentially from the wild-type N-terminus. Arrows represent /S strands.
Each /S strand is connected by a semicircle that represents a surface loop to
the following spiral that represents an a helix. The N-terminal 0a units 7'
and 8' are duplicates of the wild-type 0a units 7 and 8. Active sites at the
top. (/3a) units are connected at the bottom by semicircles representing
loops between a helices and 0 strands. Brackets indicate different possible
(/3a)8 folding frames. (A) Known circularly permuted (/3a)8 variant
(cPRAI-1, see Figure IB). (B, D) Hypothetical circularly permuted (/3a)g
variants, in which the core barrel begins with an a helix, analogous to
cPRAI-2 (see Figure 1Q. (Q Hypothetical $a\ variant. (E) Wild-type
PRAI (see Figure 1A).
Boehringer, the corresponding model substrates from Sigma.
Tryptone and yeast extract were from Oxoid. All other
biochemicals were from Merck or Sigma, of the highest purity
available.
Plasmids and strains
The vector pDS56/RBSD-l (Certa et al., 1986) with the E.coli
strain SG200-50 (strain collection by D.Stuber, personal
communication) was used for heterologous gene expression, as
described earlier (Luger et al., 1989). SG-200-50 is a lonA- (TnS)
derivative of strain MC 4110 (F-, delta LacU169, araD139, rpsL,
relA, thiA,flbB) (Casabadan, 1976). The expression-mutagenesis
vectors pMa/c with the corresponding host strains WK6 and
WK6mutS have been described by Stanssens et al. (1989). WK8
is the same as WK6 (in addition 71-18, dam-3) and was used
with the repressor plasmid pCI587.
Folding of a terminally repeated protein sequence
yPRAI
xPRAI
Met, Gln^Glu Ser Pro,*—
AAG GCA GCT TGG AGT ATG CAA GAG AGC CCC ••• AAA TAG GTT ATT ACT
Met, Arg Asp Pro Ser., Met, Gln^Glu Ser Pro^,-•• L y s ^ * * *
ATG AGG GAT CCG AGT ATG CAA GAG AGC C C C - • AAA TAG GTT ATT ACT
xPRAI MetATG AGG GAT CqG AGT ATG-
Bam HI
CAA GAT CTC CCC ••• AAA TAT GAT CAT TAG
BglH Bell
(pa)10
e U Arg Asp Leu
ATG AGG GAT CTC CCC •
Asp Pro
AAA TAT GAT CCG
Ser Met,--
AGT ATG-
ln15rAsp Leu Pro^,-- LySj^Tyr Asp His * • *
GAT CTC CCC - AAA TAT GAT CAf TAG
BglH Bell
cPRAI-1 MetsArg Asp Leu P r o m - - Lys^Tyr Asp Pro Ser Met,--- Gln^, Asp His • * *ATG AGG GAT CTC CCC •• • AAA TAT GAT CCG AGT ATG- •• CAA GAT CAT TAG
Fig. 3. Construction of the gene encoding the 03a)|0 variant of PRAI. Partial amino acid and nucleotide sequences; numbering of wild-type PRAI deduced
from the TRP1 gene (Tschumper and Carbon, 1980). New amino acids are shown in bold type. New restriction sites are underlined. (yPRAJ) Wild-type
phosphoribosyl anthranilate isomerase from yeast and the TRP1 gene. (xPRAI) Extended wild-type reference protein. The sequence changes result from
introduction of a new BamHl restriction site into the TRP-1 gene. (xPRAI*) Mutant of xPRAI. The sequence changes result from introduction of new Bgla
and Bell restriction sites. [03a) ,0] Variant of PRAI containing an N-terminal copy of the two C-terminal /3a units. A copy of fragment II was inserted into the
BamHl site of plasmkl xPRAI* in the correct orientation. (cPRAI-1) Circularly permuted 03a)8 variant of xPRAI (sec Figure IB).
Isolation of I)NA and phages
Double-stranded plasmid DNA was isolated according to
Humphreys et al. (1975; modified version for large-scale prepara-
tion) and Bimboim and Doly (1979; small scale). Single-stranded
DNA was purified after infection with the helper phage M13K07
(Pharmacia) according to the procedure described by Stanssens
etal. (1989). The ratio of single-stranded pMa/c to M13K07 was
typically 90%.
Site-directed mutagenesis
The EcoRl-Pstl fragment of the TRP1 gene (Tschumper and
Carbon, 1980) was subcloned into the EcoRl-Pstl sites of the
polylinker of pMa. Site-directed mutagenesis was performed in
pMa as described by Stanssens et al. (1989). The gapped duplex
method was used to generate the three unique restriction sites
in the TRP1 gene in three consecutive rounds of mutagenesis.
In each case the size of the gap was 800 bp. The mutagenic
oligonucleotides were 20-40 nucleotides long, depending on the
size of the mismatch, with 10—20 matching nucleotides upstream
and downstream of the mismatch. The gapped duplex was filled
in vitro using Klenow DNA polymerase and T4 DNA ligase.
The filled gapped duplexes were amplified in the strain WK6mutS
and segregated in WK6 (for the mutations generating the unique
BamHl and BgRl restriction sites), or in the darn" strain WK8
(for screening for the methylation-sensitive Bell restriction site).
In all cases, transformants were selected for their resistance
towards chloramphenicol. After the N-terminal BamHl site had
been introduced, the BamHl —PsA fragment was subcloned again
in pMa cleaved with BamHl and Pstl to enable expression of
the corresponding insert after heat induction. The mutants were
screened by checking the isolated plasmid DNA for the presence
of the new restriction site. A typical yield of 15-50% positive
mutants was routinely obtained by this procedure. Ligated
nucleotide regions were confirmed by sequencing (Sanger et al.,
1977). All other cloning methods were performed according to
standard protocols (Maniatis et al., 1982). The following
procedures were carried out as described previously (Luger et
al., 1989), unless stated otherwise.
Protein purification procedures
The (/3a) 10-variant (see Figures 2 and 3) and the mutant of
PRAI (xPRAI*, see Figure 3) were purified from inclusion bodies
as described previously with slightly lower yields for the
03a) 10- variant.
Purification of the (j3a)i0 variant from the soluble fraction. AH
purification steps were performed at 4°C, unless stated otherwise.
Transformed cells were cultivated and induced as described
previously. After harvesting, the cells were washed with 50 mM
Tris-HCl buffer, pH 8.5, containing 5 mM DTE, 2 mM EDTA
and 0.3 mM PMSF (buffer A), and resuspended to a concentra-
tion of 0.2 g of wet cells per ml in buffer A containing 0.1 %
Triton X-100. The suspension was quickly frozen in liquid
nitrogen and stored at -70°C (Miozzari et al., 1978). A 100 ml
quantity of the cell suspension was thawed in a water bath at
0—4°C. Cell debris was removed by centrifugation and after
being adjusted with water to a conductivity of 1.8 mS, the clear
supernatant was stirred gently with 50 ml of wet DEAE-Sephacel
equilibrated with buffer A. This suspension was loaded on top
of a prepacked column of DEAE-Sephacel (5 cm X 30 cm)
equilibrated with buffer A containing 0.5% Triton X-100 (final
column volume of 640 ml). The column was washed with 1 1
of buffer A at a flow rate of 4 ml/min and was then eluted with
2.4 1 of a linear gradient increasing from 0 to 250 mM NaCl
in buffer A. The active fractions were pooled and dialysed against
10 mM potassium phosphate buffer, pH 6.5, containing 100 mM
KC1, and 2 mM DTE (buffer B). The dialyzed fractions were
applied to a column of hydroxylapatite (3.6 cm X 21 cm,
215 ml), previously equilibrated with buffer B, at a flow rate
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of 34 ml/h. The column was eluted with six column volumes
of a linear gradient increasing from 10 to 250 mM potassium
phosphate pH 6.5, containing 100 mM KC1, at a flow rate of
68 ml/h. The active fractions were pooled and concentrated to
— 0.3 mg protein per ml by ultrafiltration (Amicon PM10 filter).
The protein solution was frozen rapidly by dripping into liquid
nitrogen and stored at -70°C. The yield was 32% after 49-fold
purification from the crude-extract.
Determination of molecular weight
Mr values of native proteins were determined by gel filtration
on a column of Superose 12 (1 cm X 30 cm), using a Pharmacia
FPLC system. The buffer (50 mM potassium phosphate, pH 7.5,
containing 0.1 M NaCl, 1 mM EDTA, and 1 mM DTE; buffer
C) was pumped at a flow rate of 0.12 ml/min, at 20°C. Samples
(50 /d) of lmg protein per ml were injected and the elution profile
was recorded on-line by monitoring the absorption at 280 nm.
The column was calibrated by plotting the elution volumes of
various standard native proteins versus the logarithm of the known
Mr. The standard proteins and their Mr were: cytochrome c
(12 300), horse heart myoglobin (16 950), bovine carbonic
anhydrase (30 000), hen egg white ovalbumin (43 000), bovine
serum albumin (66 300), rabbit muscle phosphorylase tj
(194 800), pig heart lactate dehydrogenase (140 000) and bovine
liver catalase (232 000). The apparent mol. wts of the unknown
proteins were interpolated from this plot.
Ultracentrifugation was carried out using a Beckman Model'
E analytical ultracentrifuge equipped with a photo-electric scanner
system. The sedimentation equilibrium was established at 2 x
104 r.p.m. All measurements were performed at 20°C using a
loading concentration of 0.5 mg protein per ml in buffer C.
Polyacrylamide gel electrophoresis in the presence of SDS was
performed according to Larnmli (1970) and Studier (1973), or
as described by Schagger and Jagow (1987). Routinely, gels with
12.5% polyacrylamide were used and stained with Coomassie
Brilliant Blue. The following standard proteins were used: rab-
bit muscle phosphorylase (97 400), bovine serum albumin
(66 300), E.coli tryptophan synthase /3-subunit (43 000), rabbit
muscle glyceraldehyde-3-phosphate dehydrogenase (35 700),
E.coli tryptophan synthase a-subunit (28 740), horse heart
myoglobin (16 950), cytochrome c (12 300) and bovine
pancreatic trypsin inhibitor (6500).
Determination of protein concentration
Protein concentrations were determined according to Bradford
(1976) using the 'Biorad Protein Assay', with bovine serum
albumin as a standard.
Unfolding and refolding studies
Equilibrium unfolding studies were carried out by monitoring
the circular dichroism at 222 nm. Data from four runs were
averaged, with the experimental error being —5%.
The reversibility of unfolding was checked by means of enzyme
activity as follows: solutions of 0.3 mg protein per ml in 50 mM
potassium phosphate buffer, pH 7.5, containing 100 mM KC1,
2 mM DTE and 2 mM EDTA (buffer D) were dialysed for
90 min against buffer D containing 4 M GuCl (buffer E).
Refolding was performed by dialysing the denatured protein
solutions for 2 h intervals against three changes of 100 vols of
buffer D. Activities were measured and compared to the activities
of protein solutions that had not been denatured but had remained
in buffer D for the same time interval. All steps were carried
out at 4°C. Three independent measurements were averaged and
the experimental error was within 3%.
Refolding kinetics. Due to the sensitivity of xPRAI and its variants
towards irradiation by UV light, measurements were done at
different times for periods of only 20 s, and the average relative
fluorescence was recorded for the midpoint of the measuring
period. The data of at least four independent measurements were
averaged.
Limited proteolysis
Proteolysis with trypsin. Protein solutions (1.5 mg protein per
ml) were dialyzed against 100 mM Tris-acetate buffer, pH 7.6,
supplemented with 1 mM EDTA and 1 mM DTE (buffer F).
Trypsin was dissolved in 1 mM HC1 at a concentration of
0.5 mg/ml. A 200 /*1 aliquot of the protein solution was mixed
with 5 ftl of trypsin stock solution and incubated at room
temperature. At the time intervals given in Figure 5, samples
were removed from the incubation mixture, mixed with the same
volume of sample buffer (Lammli, 1970), and heated for 5 min
at 100°C. Parallel samples were used to assay the activity of PRA
isomerase as described previously. The heated samples were
subsequently analyzed by gel electrophoresis in the presence of
SDS as described above. The activity of the protease under the
described conditions was checked by degradation of tryptophan
synthase /32 subunit from E.coli. The characteristic fragments
(Hogberg-Raibaud and Goldberg, 1977) appeared within 10 min
at room temperature.
• Proteolysis with LysC and ArgC endopeptidases. A 250 /ig
amount of protein in a final volume of 250 y\ of buffer F was
mixed with either 3 milliunits of LysC or 5 units of ArgC protease
dissolved in buffer F, and incubated at 25°C. Samples taken after
different time intervals were treated as described above. The large
proteolytic fragment (Mr ~ 25 000) was purified from a parallel
batch by gel filtration on a column of Superose 12. The
preparations were checked for homogeneity by gel electrophoresis
in the presence of SDS and were then used for determining the
amino-terminal sequence (Luger et al., 1989).
Proteolysis with factor Xa. Activation of factor X was achieved
by adding 25 /tl of Russel's Viper venom to a solution of 0.25 mg
of factor X per ml of 8.3 mM Tris-HCl buffer, pH 8.0,
containing 8.3 mM CaCl2 and 67 mM NaCl (Nagai and
Thogersen, 1987). The mixture was incubated for 1 h at 37°C.
The activated factor X (designated Xa) was stored in aliquots at
—20°C. Protein samples were adjusted to a concentration of 2
mg protein per ml in 50 mM Tris-HCl buffer, pH 8.0, con-
taining 100 mM NaCl and 1 mM CaCl2 (buffer G). Protein
stock solution (20 y\) was mixed with 100 /*1 of Xa stock
solution, and the concentration of the buffer was adjusted to
50 mM by adding 10 /*! of 10-fold concentrated buffer G. After
different incubation times, parallel aliquots were either used for
enzyme assays or were heated for 5 min at 100°C in sample
buffer and subjected to gel electrophoresis in the presence of SDS
as described above. As a control for the activity of Xa, 42 ng
of prothrombin was digested with 3 fig of Xa under the above
conditions. Proteolysis of prothrombin to thrombin, as analyzed
by gel electrophoresis in the presence of SDS, was completed
after 1 h. The large proteolytic fragment was purified and
sequenced as described above.
Results
Constructions
The construction of the coding sequence of the (/9a)
 10 variant
of yeast PRAI that is shown schematically in Figure 2 is
summarized in Figure 3. Introduction of a unique BamW site
252
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Table I. Steady-state and refolding kinetics
Protein
Extended PRAI (xPRAP)
Mutant PRAI (xPRAJ*1)
Circularly permuted PRAI (cPRAJ-11)
03a)
 l0 variantb
03a) 10 variant1'
03a) io variant*1
of 03a)8 wild-tye, 03a)8
Quality
refolded, fresh
refolded, stored
refolded, fresh
pristine, stored
refolded, fresh
refolded, stored
circularly permuted and 03or)io variants of yeast
Steady-state constants
(s-1)
79 ± 8
28 ± 9
59 ± 3
27 ± 5
39 ± 6
22 ± 7
K
0.M)
3.7 ± 0.6
3.4 ± 0.4
5.5 ± 0.5
2.7 ± 0.2
2.7 ± 0.2
3.0 ± 0.2
PRAI
*<-
0»M~'s~')
21
8
11
10
14
7
Slow refolding
rate constant
ft?
3.5 ± 0.2
nd
1.7 ± 0.1
nd
1.7 ± 0.1
nd
k^ and Km values measured by monitoring disappearance of substrate as described (Luger et al., 1989). 50 mM Tris-HCl buffer, pH 7.5, at 25°C. k^ is
the rate constant of the slow phase of refolding from 4 M GuCl solutions in 50 mM potassium phosphate buffer, pH 6.5, containing 0.1 M KC1, 20 mM
DTE and 10 mM K2Mg-EDTA, at 20°C. nd: not determined.
°See Figure 1.
bSee Figure 2.
cSee Figure 3.
was required to subclone the TRP-1 gene (Tschiimper and Car-
bon, 1980) into a vector allowing high expression in E.coli. This
mutation led to the extension of the wild-type PRAI (Figure 3,
yPRAI) by five amino acids at the N-terminus (Figure 3, xPRAI).
Because all variants discussed in this work begin with similar
short extensions, we consider xPRAI to be the proper reference
wild-type (fia)s protein.
Introduction of the new Bg/II and Bell sites that were required
for the subsequent translocation step led to another mutant of
yPRAI (Figure 3, xPRAI*) that has the two substitutions
Glul68Asp, Serl69Leu in the loop between a helix 6 and (1
strand 7 (see Figure 1 A) and three extra amino acid residues (Tyr,
Asp and His) at the C-terminus. The properties of xPRAI* are
interesting because the folding frames B, C, D and E depicted
in Figure 2 differ from the sequence of xPRAI at positions 168
and 169.
Insertion of a duplicate of the coding region II into the BamHl
site of the gene of xPRAI* led to the continuous coding sequence
of the 0Sa)io variant [Figure 3, (j3a)|0], which has the same
C-terminus as xPRAI*. The partial sequence of cPRAI-1 (see
Figure IB) is shown for comprison in the bottom line of Figure 3.
Purifications
xPRAI* and the 03a)|O variant were expressed in E.coli as
described previously for xPRAI and cPRAI-1. Again the major
fraction of each overproduced protein was insoluble. After
disruption of the cells and centrifugation, the pellets were
dissolved in concentrated solutions of GuCl, refolded and purified
by the procedure described previously. A pure protein was
obtained with 60% yield after — 2-fold purification from the
dissolved pellets (data not shown).
The cytoplasmic fraction contained ~ 5 % of the total
recoverable activity. It was used to purify pristine protein that
had not passed through a cycle of aggregation, unfolding and
refolding. All subsequent studies were done with both xPRAI*
(see Figure 3) and the refolded (J3a)l0 variant, if not stated
otherwise.
Determination of the molecular weight
To exclude the possibility that activity depends on the formation
of dimers (Jackson and Yanofsky, 1969a,b) the mol. wts of
xPRAI* and of the pristine and refolded (j3a)iO-variants were
determined by three independent methods. Gel electrophoresis
in the presence of dodecyl sulphate showed good agreement with
the calculated Mr of 32 000 [(/3a)10 variant] and 25 000
(xPRAI*; data not shown). Similar data were obtained by gel
filtration of the native proteins on a column of Superose 12 and
by equilibrium ultracentrifugation (data not shown). These results
prove that xPRAI* as well as both (/3a)10 variants from the
cytoplasm and the insoluble fraction are monomeric under native
conditions.
Steady-state kinetics
The active site of PRAI is formed by residues located in several
of the /3 strands and their following loops (Priestle et al., 1987).
None of the alterations necessary for constructing either xPRAI*
or the (j3a)1o variant involve any of the active site residues or
their immediate sequence neighbours (see Figures 2 and 3).
Therefore, KM and k^ values should be sensitive indicators of
the integrity of the overall structure of the central 03a)8 core.
The steady-state kinetic parameters of xPRAI, xPRAI* and the
(j3a)|0 variants are shown in Table I.
The most important finding is that the KM values of the
pristine and the refolded (Jia)i0 variants were quite similar to
those of the reference (xPRAI) and mutant (xPRAI*) (/3a)8
proteins. The k^ values were ~ 2-fold smaller, but the effect
of prolonged storage accounts for part of the decrease. In
summary, these preliminary data indicate that xPRAI* and both
03a)io variants have active sites that are very similar to that of
the reference protein. However, since two of the folding frames
depicted in Figure 2, namely those of xPRAI and cPRAI-1, have
practically the same KM and k^ values (see Table I), these data
cannot be used to distinguish between different folding frames.
We therefore turned to the following qualitative method to make
the distinction.
Limited proteolysis with endoproteases
If the tertiary structure of the 09a),0 variant consists of a OSo;)g
barrel core (see Figure 2), the terminal extension(s) are probably
joined by flexible linkers to the core, and therefore should be
removable by endopeptidases. The reference (/?a)8 protein
xPRAI and its two circularly permuted (fia)s variants cPRAI-1
and cPRAI-2 are resistant towards proteolysis by trypsin, ArgC
and LysC proteases and factor X,,, despite the presence of
numerous potential cleavage sites in loop regions as well as in
external a helices (Luger et al., 1989). By treatment of the
Q3a) io variant with different endopeptidases under native
conditions, and by sequencing of the N-termini of the resulting
253
K.Luger, H.Szadkowski and K.Kirschner
B P7
C a7
H I SDWVGRQDLPESL |HFM
I I
160 " 0
MLA| GGLTPEN
I
180
d-7
NGVIG |VDV
I I
190 200
M 0 0.25 0.5 1 2 U 16 X M
32 kD-
25kD-
D P8 VS| GGVETNGVKD
I I
200 210
T V V
KYDPSMSVINFTGSSGP |LVK-
I I
P,
220 10
Fig. 4. Oligopeptide linkers of the (fia)l0 variant of PRAI between various
(/Ja)g cores and their corresponding terminal extensions. Folding frames A,
B, C, D and E as well as the numbering of segments of secondary structure
as in Figure 2. Amino acid residues in single letter code are numbered as in
Figure 3, and comprise the sequence of xPRAI* from Asnl58 to the C-
terminal Lys224. Residues in secondary structures (a: or helix; /?: 0 strand)
are boxed. Boundaries of secondary structure segments are derived from
model building of the sequence of yeast PRAI using the refined coordinates
of PRAI from E.coli (Priestle el ai, 1987; M.Wilmanns and J.N.Jansonius,
personal communcation). (V) Potential and ( • ) actual cleavage sites for
various endopeptidases described in the text.
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peptidase-resistant cores, we attempted to gain information on
the precise boundaries of the (/3a)8 barrel cores, that is, on the
actual folding frame. Comparison of the folding frames of both
the pristine and the refolded (/3a)io variants should show
whether the product of folding in vivo is different from that in
vitro.
When the refolded (/3a),0 variant (Mr 32 000) was treated
with trypsin, it was degraded to a stable fragment with an Mr
of ~ 25 000, as judged by gel electrophoresis in the presence
of SDS. The PRAI activity remained unchanged by comparison
to the control without protease (data not shown). These results
indicate that limited digestion with trypsin removes the terminal
extension(s), wherever they are, and leaves an active (/Sa)8
barrel core intact.
Figure 4 presents the various surface loops of the (j3a)io
variant that are potential linkers between the five different possible
(/3a)g cores and their respective terminal extensions (see Figure
2). As indicated by the triangles above the amino acid sequence,
only the loops between a6 and /J7 (Argl66), /38 and a8 (Lys210)
and a8 ' and /S, (Lys223 and Lys224) contain potential cleavage
sites for trypsin. The previous observation that the circularly
permuted (/Ja)8 variant cPRAI-1 (Figure IB) is not cleaved by
trypsin shows that the new link between a8 ' and j3t is
inaccessible to proteases when it is part of a (fia)g core.
To identify the site of cleavage by trypsin we used separately
the more specific endopeptidases ArgC and LysC, which cleave
Arg—Xaa and Lys—Xaa peptide bonds, respectively. The loop
between a8 ' and /3, contains only two sites for LysC (Lys223
and Lys224), whereas the loop connecting a6 and /37 has only
one potential cleavage site for ArgC (Arg 166). Therefore,
cleavage of the 03a) |0 variant with LysC to a fragment of Mr
25 000 with retention to full PRAI activity would support the
folding frame E, whereas complete cleavage with ArgC would
support folding frame A. A mixture of two or more non-
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Fig. 5. The (fia)l0 variant is trimmed by LysC and ArgC endopeptidases.
Kinetics of limited proteolysis measured by gel electrophoresis in presence
of SDS. Lane M: Mr of marker proteins, from top to bottom: 97 000,
67 000, 43 000, 35 000, 29 000, 17 000, 12 000 and 6500. Lane X: wild-
type reference protein xPRAI, Mr 25 000. Lanes 0—16 indicate incubation
period, in hours. The percentages below the shots show retention of PRAI
activity at the indicated times in the absence ( - ) and presence (+) of the
respective endopeptidase. (A) Action of LysC endopeptidase. (B) Action of
ArgC endopeptidase.
equilibrating folding frames would be indicated by the inability
of each protease to degrade all of the molecules to Mr 25 000
fragments.
Contrary to expectation, both proteases led to complete
degradation of the (/3a) io variant to fragments of Mr 25 000
(Figure 5) that retained — 80% of the original enzymic activity.
The large fragments were not degraded further, even after
prolonged incubation. We used two different methods of gel
electrophoresis for detecting polypeptide fragments in the Mr
range 4000-10 000 (Lammli, 1970; Schagger and Jagow, 1987),
but obtained no evidence for the extraneous (|3a)2 region of Mr
7000 expected as the other product of limited proteolysis of
folding frame E (see Figure 2). The peptide of Mr —7000
observed in Figure 5(B) is a contaminant of the (J3a)i0 prepara-
tion present at zero time of incubation.
The Mr 25 000 fragments obtained with each protease were
purified and the respective N-terminal amino acid sequences were
determined. LysC protease produced a unique fragment with the
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N-terminal sequence KYDPSMSVINF. . ., and ArgC protease
produced a fragment with NAKKYD. . . Thus both proteases
cleaved peptide bonds that are in or at the end of a helix 8' rather
than in the loop connecting as' with /3b suggesting that the
(/3a) |0 variant possesses the folding frame E of the reference
wild-type protein (see Figure 2).
Since no intermediate accumulated transiently in the course
of proteolysis of 03a) 10 by LysC protease (Figure 5A), it
appears that the Lys210'—Asp211' bond located in the loop
connecting /3g' and a8 ' (see Figure 4) was cleaved more slowly
than the Lys223 - Lys224 bond. ArgC protease cleaved at one
of the LysC-specific sites (Lys220'-Asn221'), for unknown
reasons. The important observation is that none of the Arg—Xaa
bonds that are located at the limits of the (/3a)8 cores of the
other possible folding frames (e.g. Argl66-Gln in frame A,
Arg 191 -Leu in frame C; see Figure 4) were cleaved by ArgC
protease. The observed intermediate fragment of Mr 30 000
(Figure 5B) could be due to specific cleavage at residue Arg 191'
at the end of a7 ' , before cleavage at Lys220' occurs.
In order to detect a minor fraction that possibly could possess
the folding frame A, the (fia)w variant was digested with the
blood plasma factor X,,. This extremely specific protease cleaves
mainly at De-Glu-Gly-Arg-1-Xaa [the site of cleavage is indicated
by an arrow (Coghlan and Vickery, 1989; Husten et al., 1987)],
but sometimes also at Gly-Arg-t-Xaa (Nagai and Thogersen,
1987). The only potential cleavage site for Xa is in the loop
connecting a6 with (37 (. . .Gly-Argl66-t-Gln. . .; see
Figure 4).
Even after long incubation times with large amounts of factor
Xa endopeptidase, only partial degradation of the (/3a)|0 variant
to an Mr 25 000 fragment was observed. Again, the PRAI
activity remained practically constant (data not shown).
N-Terminal sequencing of the purified Mr 25 000 fragment
revealed that it consisted of a mixture of peptides with at least
two different N-termini. However, the two main sequences
(NAKKYDP. . . and KYDPSM. . .) prove that cleavage
occurred at the sites attacked by LysC and ArgC proteinases (see
Figure 4). The unexpected cleavage sites within the (j3a)|0
variant cannot be due to thrombin, which is known to be the
predominant contamination of preparations of factor Xa (Nagai
and Thogerson, 1987), because thrombin is specific for Arg—Xaa
bonds. It is unclear whether plasmin or some other protease is
the responsible agent. Neither xPRAI nor cPRAI-1 were degraded
by our preparation of factor Xa. Therefore the loops connecting
a6 with /37 in xPRAI and a8 ' with /3i in cPRAI-1 were
inaccessible to both factor Xa and the unknown contaminating
protease.
The 03a) io variant that was purified from the cytoplasm was
also treated with both LysC and ArgC proteases. However, the
SDS gel patterns were identical to those of the molecule refolded
in vitro. The corresponding proteinase-resistant cores also retained
full PRAI activity (data not shown), and the sequence of the LysC
fragment (KYDPSM. . .) agreed with the sequence obtained from
the LysC fragment of the refolded molecule. Therefore, according
to the criterion of susceptibility to endopeptidases, both the
pristine and the refolded 03a) IQ variant must have the same
folding frame.
Spectroscopic measurements
In order to obtain independent information on whether the
N-terminal 03a)2 extension is folded or not, we compared the
circular dichroism (CD) spectra of the 03a)io variant to those
of the reference protein xPRAI* and the circularly permuted
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Fig. 6. The circular dichroism spectrum of the 03a)
 !0 variant is very similar
to that of the (fia)s wild-type reference protein. Measurements in 0.05 M
potassium phosphate buffer, pH 7.5, at 20°C in d = 0.1 cm cuvettes. Solid
line: 0.7 mg xPRAI/ml. Dashed (cPRAI-1) and dotted lines l(fia)l0 variant]
are at concentrations giving the same mean residue concentration as xPRAI.
03a)g variant cPRAI-1. The protein solutions were adjusted to
the same optical density at 230 nm, where the absorption of the
peptide bonds is additive (Cantor and Schimmel, 1980), to ensure
that each measurement was performed with an identical
concentration of mean amino acid residues. The terminal
extension of the 03a)
 l0 variant increases the number of residues
and potential secondary structure segments of the sequence of
the reference protein by 25%. Therefore, a completely random
conformation of the extension would decrease the mean residue
ellipticity by - 2 0 % .
However, the normalized CD spectra were identical within the
experimental error (±5%) for all three proteins (Figure 6). It
appears that the additional (fi-ra-jfigctg)' fragment has a similar
average content of secondary structure to that when it is part of
the folded reference protein. The UV absorption and fluorescence
emission spectra (excited at 280 nm), which were measured under
the same conditions, were identical for the same three proteins
within the experimental error. They provide little information
on the secondary and tertiary structure of the extension and are
therefore not shown here, because the 58 extra amino acids
contain neither Tyr nor Tip and only two Phe residues (see
Figures 3 and 4).
Equilibrium unfolding and refolding
To investigate the intrinsic stability of the 03a)io variant and to
assess the influence of the terminal extension, we measured the
equilibrium unfolding and refolding transitions and compared
them to those of the reference protein (xPRAI) and one of the
circularly permuted variants (cPRAI-1).
As shown in Figure 7, the overall GuCl-dependent unfolding
transitions of both the 03a)
 10 variant and xPRAI (as measured
by CD at 222 nm) were practically indistinguishable, whereas
that of cPRAI-1 was displaced more towards lower concentra-
tions of GuCl.
255
K.Luger, H.Szadkowskl and K.Kirscbner
Rg. 7. The unfolding transitions of the (/3a)10 variant and the (/3a)8 wild-
type reference protein at equilibrium are very similar. Averaged
measurements are presented of circular dichroism at 222 run in the presence
of the indicated concentrations of GuCl in the buffer under Fig. 6, at 20°C.
The linear change of mean residue ellipticity (#222) above 3 M GuCl was
extrapolated to 0 M GuCl. / N is the normalized deviation of #222 from this
base line. (O) Wild-type (0a)s, xPRAI. (A) 03a)]O variant. (D) Circularly
permuted (/3or)8, cPRAI-1.
The reversibility of unfolding was demonstrated by refolding
experiments using dialysis. At a protein concentration of
0.3 mg/ml, the yield of enzymic activity after one round of
unfolding and refolding was close to 100% for xPRAI, xPRAI*,
cPRAI-1 and the (fia)]0 variant (data not shown). Similar
findings have also been reported for enolase (Teipel and
Koshland, 1971), aldolase (Rudolph et al., 1983) and the a
subunit of tryptophan synthase (Jackson and Yanofsky, 1969a;
Yutani etal., 1977; Matthews and Crisanti, 1981). High refolding
yields may be an intrinsic property of (J3a)% barrel proteins.
Refolding kinetics
As a preliminary check whether the N-terminal (fia)j region
affects the kinetics of refolding of the (fia)l0 variant, refolding
was initiated by rapid dilution of GuCl-containing solutions and
monitored by tryptophan fluorescence. The progress curve
consisted of both a rapid (half-time t^ < 1 s) and a slow phase,
as observed previously in the case of the reference protein xPRAI
and one of the circularly permuted variants cPRAI-1 (Luger et
al., 1989). The latter phase, which has an amplitude of only 33%
of the total amplitude, was fitted to a single exponential and the
rate constants were compared to those of xPRAI and cPRAI-1
(see Table I). The rate constants of the slow refolding phase of
cPRAI-1 and the (0a)
 i0 variant were approximately half that of
xPRAI. Preliminary studies with cPRAI-1 involving CD
measurements indicate that a large fraction of the total amplitude
was attained immediately after dilution (K.Luger, unpublished
data), and we assume that this is true for all diree proteins.
Therefore the presence of a duplicated region of the C-terminus
fused to the N-terminus does not affect significantly the slow
phase of folding of the (fia)s core.
Discussion
The initial investigations reported here show that the wild-type
(/3a)8 region of the (0a),0 variant of PRAI folds with the same
overall rate and to the same extent as the wild-type reference
03a)8 protein. Moreover, the product of folding in vivo is the
same as that of folding in vitro.
It is pertinent to ask whether an equilibrium exists between
the differing folding frames shown in Figure 2. If such were the
case and only the wild-type conformer were susceptible to attack
by endopeptidases, the population would be shifted entirely
towards that species, and the results of Figure 5 would be
misleading.
The properties of another 8-fold fia barrel protein, namely the
a subunit of tryptophan synthase (Hyde et al., 1988), have some
bearing on this question. The a subunit forms non-covalent
complementing dimers by mutual exchange of terminal regions
of the polypeptide chain (Jackson and Yanofsky, 1969a). It also
forms stoichiometric complexes with duplicate polypeptide
fragments (Jackson and Yanofsky, 1969b). In that the (J3a)i0
variant of PRAI contains redundant regions of polypeptide
sequence at its termini, it represents a single-chain equivalent
to the complexes of the a subunit with duplicate fragments.
The important observations of Jackson and Yanofsky (1969a,b)
in this regard is that these enzymically active complexes could
only be formed by dissolving the protein (and the fragments) at
high concentrations in 6 M urea and then removing the urea by
dialysis. Moreover, these dimers and complexes could be
dissociated by heating only at ~50°C, which is close to the
thermal unfolding transition of the a subunit (Matthews et al.,
1982; Yutani et al., 1982). We conclude that it is not very likely
that the exchange of redundant segments that would be required
during the transition from one folding frame of the 03a)
 10
variant of PRAI to the other can take place under native con-
ditions.
Another question is whether the final structure of 03a) 10
variant is preferred thermodynamically or rather is trapped
kinetically in a metastable conformation. In this regard it is
interesting that the direction of protein biosynthesis does not bias
the folding of the (fia)10 variant. If its folding were more rapid
than its synthesis, the first stable 03a)8 core to be completed on
the ribosome, namely folding frame E (Figure 2), would be
trapped kinetically. That is, even if alternative, more stable
folding frames were to become available as the polypeptide chain
is elongated further, they would have no opportunity of folding.
By contrast, if protein folding were slower than protein synthesis,
the processive nature of polypeptide chain elongation would not
affect the final structure.
Although the half-life of the slowest phase of the fluorescence
change observed during refolding from GuCl solutions is ~ 500 s
(see Table I, t,h = In 2/k^, it is premature to conclude from
these data that folding in vivo is slower than synthesis (elongation
rate ~ 15 amino acids added/s). The slow refolding steps
observed in vitro with the analogous a subunit of tryptophan
synthase are probably due to the isomerization of Xaa—Pro bonds
having non-native geometry (Cristanti and Matthews, 1981).
Although it is not known which of the 11 Xaa-Pro bonds of
pPRAI are generated in the wrong configuration during synthesis,
none of these residues are located in /3 strands or a helices
(M.Wilmanns, unpublished work). By contrast, aldolase from
Staphylococcus aureus, which is probably another monomeric
03a) barrel protein (Matsuura et al., 1984; Buisson et al., 1987),
refolds within 10 s (Rudolph et al., 1983). Thus it is possible
that the 03a)8 cores of both the 03a)8 and the (/to) 10 variants
fold rapidly and that the slow final phase of folding, which is
characterized by fc^ (see Table I), is due to the isomerization
of peripheral Xaa-Pro bonds. In summary, the circumstantial
evidence favours the view that the folding of the 03a) m variant
to yield exclusively the wild-type 03a)8 core is controlled
thermodynamically (Anfinsen and Scheraga, 1975).
Why is folding frame E (see Figure 2) preferred over the other
possible ones? Perhaps the different circularly permuted (0a)
variants of PRAI are intrinsically less stable than the wild-type.
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Indeed, the concentration of GuCl at the midpoint of the unfolding
transition of cPRAI-1 is slightly less than that of the reference
(j3a)g protein (Figure 7). To test this hypothesis we have
constructed and tested a terminally repeated variant of PRAI that
carries the C-terminal region comprising ctffi-jcijPgag joined to
the N-terminus (K.Luger, unpublished experiments). This
03a) 10.5 variant has the unorthodox (aj3)8 core of cPRAI-2 (see
Figure 1C) as the first folding frame to be synthesized on the
ribosome. Furthermore, cPRAI-2 and the reference wild-type
protein have superimposable unfolding transitions with GuCl as
the denaturant (Luger et al., 1989). However, the folding frames
of both the pristine and the refolded forms of the (/3a)ioj variant
were again the same, namely that of the wild-type 03a)g core
(data not shown). We conclude that the mid-point of the unfolding
transition due to GuCl is not a sufficient criterion to predict the
preferred folding frame of terminally duplicated variants.
Another explanation for the preference of the wild-type core
is that, fortuitously or not, its interaction with the N-terminal
extension represents the structure of minimal free energy. In this
regard it is interesting that both the a subunit of tryptophan
synthase (Hyde et al., 1988) and indoleglycerol phosphate syn-
thase (Priestle et al., 1987) possess structured extensions at their
N-termini.
The CD spectra are consistent with the idea that the redundant
segments of polypeptide chain have approximately the same
content of a helix as the same segment in the corresponding
compact 03a)g domain. However, the data could also be
explained by assuming a collapsed, partially folded and rapidly
fluctuating state of the extension (Ptitsyn, 1987; Ohgushi and
Wada, 1983; Shortle and Meeker, 1989; Baum et al., 1989).
A more direct determination of the structure of the 03a) io
variant is needed to answer the important question of how the
redundant chain segment interacts with the 03a)8 barrel core.
Complementary information is to be expected from the properties
of the intermediate stages of the folding pathway, where the final
folding frame is selected. Experiments based on these considera-
tions are in progress.
Proteins with terminally repeated sequences may represent
transient intermediates during their evolution. About 30% of the
presently known proteins have adjacent N- and C-terminal regions
(Thornton and Sibanda, 1983). Therefore, at least in principle,
they may have been subject to the same kind of strategy as used
in this work on an 8-fold /3a barrel protein. Tandem duplica-
tions and transpositions at the genetic level have been shown to
occur spontaneously. At a later stage, superfluous extensions
could have been trimmed to generate circularly permuted
sequences (Cunningham et al., 1979).
More importantly, the new extensions or insertions might have
been crucial for modulating the intrisic properties of the wild-
type protein. One advantage of this hypothetical mechanism of
protein evolution is that each of the several new folding frames
would probably retain partial activity. But, besides being more
stable, the preferred configuration of (fia)g core and terminal
extensions could fortuitously be more active, or have some other
new property, thus possibly affecting the generation time of the
organism in a crucial manner.
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